SCH 13G/A FILING FOR MFN PARTNERS (FILER) AND ISSUER ACLARIS, TO BE FILED IN FEB

Company

Aclaris Therapeutics, Inc.

Filed

February 13, 2020

Accession Number

0000904454-20-000171